These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 6144283)
21. Retrospective evaluation of the dose equivalence of Botox(®) and Dysport (®) in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story. Bentivoglio AR; Ialongo T; Bove F; De Nigris F; Fasano A Neurol Sci; 2012 Apr; 33(2):261-7. PubMed ID: 21710123 [TBL] [Abstract][Full Text] [Related]
22. Clinical features of patients with blepharospasm: a report of 240 patients. Peckham EL; Lopez G; Shamim EA; Richardson SP; Sanku S; Malkani R; Stacy M; Mahant P; Crawley A; Singleton A; Hallett M Eur J Neurol; 2011 Mar; 18(3):382-6. PubMed ID: 20649903 [TBL] [Abstract][Full Text] [Related]
23. FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. Blackburn MK; Lamb RD; Digre KB; Smith AG; Warner JE; McClane RW; Nandedkar SD; Langeberg WJ; Holubkov R; Katz BJ Ophthalmology; 2009 May; 116(5):997-1001. PubMed ID: 19410958 [TBL] [Abstract][Full Text] [Related]
24. Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs. Bentivoglio AR; Fasano A; Ialongo T; Soleti F; Lo Fermo S; Albanese A Neurotox Res; 2009 Apr; 15(3):224-31. PubMed ID: 19384595 [TBL] [Abstract][Full Text] [Related]
25. Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection. Casse G; Adenis JP; Sauvage JP; Robert PY Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1307-14. PubMed ID: 18581129 [TBL] [Abstract][Full Text] [Related]
26. [Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A]. Vogt T; Lüssi F; Paul A; Urban P Nervenarzt; 2008 Aug; 79(8):912-7. PubMed ID: 18551268 [TBL] [Abstract][Full Text] [Related]
27. Animal models of focal dystonia. Evinger C NeuroRx; 2005 Jul; 2(3):513-24. PubMed ID: 16389315 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm. Roggenkämper P; Jost WH; Bihari K; Comes G; Grafe S; J Neural Transm (Vienna); 2006 Mar; 113(3):303-12. PubMed ID: 15959841 [TBL] [Abstract][Full Text] [Related]
29. Spontaneous and reflex activity of facial muscles in dystonia, Parkinson's disease, and in normal subjects. Deuschl G; Goddemeier C J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):320-4. PubMed ID: 9527141 [TBL] [Abstract][Full Text] [Related]
30. Blepharospasm: a review of 264 patients. Grandas F; Elston J; Quinn N; Marsden CD J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):767-72. PubMed ID: 3404184 [TBL] [Abstract][Full Text] [Related]
31. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. Kraft SP; Lang AE CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771 [TBL] [Abstract][Full Text] [Related]
32. Hysterical symptoms in ophthalmology. Weller M; Wiedemann P Doc Ophthalmol; 1989 Sep; 73(1):1-33. PubMed ID: 2698334 [TBL] [Abstract][Full Text] [Related]